| Literature DB >> 26696985 |
Javier A Gimpel1, Vitalia Henríquez2, Stephen P Mayfield3.
Abstract
The great phylogenetic diversity of microalgae is corresponded by a wide arrange of interesting and useful metabolites. Nonetheless metabolic engineering in microalgae has been limited, since specific transformation tools must be developed for each species for either the nuclear or chloroplast genomes. Microalgae as production platforms for metabolites offer several advantages over plants and other microorganisms, like the ability of GMO containment and reduced costs in culture media, respectively. Currently, microalgae have proved particularly well suited for the commercial production of omega-3 fatty acids and carotenoids. Therefore most metabolic engineering strategies have been developed for these metabolites. Microalgal biofuels have also drawn great attention recently, resulting in efforts for improving the production of hydrogen and photosynthates, particularly triacylglycerides. Metabolic pathways of microalgae have also been manipulated in order to improve photosynthetic growth under specific conditions and for achieving trophic conversion. Although these pathways are not strictly related to secondary metabolites, the synthetic biology approaches could potentially be translated to this field and will also be discussed.Entities:
Keywords: PUFA; biodiesel; biohydrogen; carotenoids; metabolic engineering; microalgae; photosynthesis; transformation
Year: 2015 PMID: 26696985 PMCID: PMC4678203 DOI: 10.3389/fmicb.2015.01376
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Metabolic engineering reports for lipid synthesis in microalgae.
| Target protein | Host | Type of modification | Gene source | Primary phenotype change | Reference |
|---|---|---|---|---|---|
| ACCase∗ | Nuclear oversexpression | Endogenous | No increase in total lipid accumulation | ||
| Acetyl-CoA carboxylase | |||||
| PDK | Antisense cDNA | 82% increase in neutral lipids | |||
| Pyruvate dehydroganase kinase | |||||
| Malic enzyme | Nuclear oversexpression | Endogenous | 2.5-fold increase in total lipids | ||
| Multifunctional lipase | RNAi | 3.3-fold increase in total lipids | |||
| TE∗ | Nuclear overexpression | Two higher plants | No increase in total lipid accumulation | ||
| Increased production of C12 and C14 FA | |||||
| TE∗ | Nuclear overexpression | Endogenous | 82% increase in total FAs | ||
| No change in chain-lengths profile | |||||
| TE∗ | Nuclear overexpression | Two higher plants | No increase in lipids for all genes | ||
| Endogenous | Shorter chain FA with the endogenous gene | ||||
| DGAT∗ | Nuclear overexpression | Three endogenous | No increase in TAG accumulation | ||
| No changes in TAG profiles | |||||
| DGAT∗ | RNAi; three target genes | 24 and 37% decrease in TAGs with two genes | |||
| 34% increase in TAGs with one gene | |||||
| Five TAG biosynthetic enzymes∗ | Nuclear overexpression | 2 yeasts | Twofold increase in TAGS with five genes | ||
| No change with individual genes | |||||
| Lipid trigger transcription factor | Nuclear overexpression | Endogenous | 11% increased total extractable lipids | ||
| Lipogenesis transcription factor | Nuclear overexpression | Soybean | 52% increase in total lipids | ||
| Δ4 desaturase∗ | Nuclear overexpression microRNA | Endogenous | Increased accumulation of FA 16:4 | ||
| Decreased accumulation of FA 16:4 | |||||
| Δ5 desaturase∗ | Nuclear overexpression | Endogenous | 58% increased accumulation of EPA | ||
| 65% more neutral FA |
Metabolic engineering reports for terpenoid biosynthesis in microalgae.
| Target protein | Host | Type of modification | Gene source | Primary phenotype change | Reference |
|---|---|---|---|---|---|
| Geranylgeranyl-pyrophosphate synthase | Plastid overexpression | Archeabacterium | No changes in isoprenoid profile | ||
| PSY∗ | Nuclear overexpression | 2.6-fold increase in lutein | |||
| PSY∗ | Nuclear overexpression | 2.2-fold increase in lutein | |||
| PDS∗ | RNAi | 93% reduction of mRNA | |||
| PDS∗ | Nuclear overexpression | Endogenous w/mutation | Increase of several carotenoids Norflurazon resistance | ||
| PDS∗ | Nuclear overexpression | Endogenous w/mutation | 32.1% increase in total carotenoids | ||
| PDS∗ | Nuclear overexpression | Endogenous w/mutation | 26% increase in astaxanthin | ||
| PDS∗ | RNAi | 72% reduction of mRNA | |||
| BKT∗ | Nuclear overexpression | No keto-carotenoids detected | |||
| BKT∗ | Nuclear overexpression | 4-keto-lutein detected | |||
| Squalene synthase | Nuclear overexpression | Endogenous | Squalene was not detected | ||
| Squalene epoxidase | RNAi | 56–76% knock-down of mRNA |